BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gou S, Huang Y, Wan Y, Ma Y, Zhou X, Tong X, Huang J, Kang Y, Pan G, Dai F, Xiao B. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis. Biomaterials 2019;212:39-54. [DOI: 10.1016/j.biomaterials.2019.05.012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 20.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, He Q, Sun J, Gong H, Cao Y, Duan L, Yi S, Ying B, Xiao B. Near-Infrared-Enpowered Nanomotor-Mediated Targeted Chemotherapy and Mitochondrial Phototherapy to Boost Systematic Antitumor Immunity. Adv Healthc Mater 2022;:e2200255. [PMID: 35536883 DOI: 10.1002/adhm.202200255] [Reference Citation Analysis]
2 Wang X, Gu H, Zhang H, Xian J, Li J, Fu C, Zhang C, Zhang J. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy. ACS Appl Mater Interfaces 2021;13:33948-61. [PMID: 34261306 DOI: 10.1021/acsami.1c09804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sun L, Ouyang J, Zeng F, Wu S. An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome. Biomaterials 2022;283:121468. [DOI: 10.1016/j.biomaterials.2022.121468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang L, Yu M, Yang H. Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease. J Inflamm Res 2021;14:1701-16. [PMID: 33953597 DOI: 10.2147/JIR.S304101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gou S, Huang Y, Sung J, Xiao B, Merlin D. Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases. Nanomedicine (Lond) 2019;14:2373-8. [PMID: 31290366 DOI: 10.2217/nnm-2019-0058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
6 Luo J, Gong T, Ma L. Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management. Carbohydr Polym 2020;249:116887. [PMID: 32933700 DOI: 10.1016/j.carbpol.2020.116887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
7 Chen Y, Tie S, Zhang X, Zhang L, Tan M. Preparation and characterization of glycosylated protein nanoparticles for astaxanthin mitochondria targeting delivery. Food Funct 2021;12:7718-27. [PMID: 34286807 DOI: 10.1039/d1fo01751a] [Reference Citation Analysis]
8 Ma Y, Canup BSB, Tong X, Dai F, Xiao B. Multi-Responsive Silk Fibroin-Based Nanoparticles for Drug Delivery. Front Chem 2020;8:585077. [PMID: 33240846 DOI: 10.3389/fchem.2020.585077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Jansen SA, Nieuwenhuis EES, Hanash AM, Lindemans CA. Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunol 2022. [PMID: 35654837 DOI: 10.1038/s41385-022-00527-6] [Reference Citation Analysis]
10 Gou S, Yang J, Ma Y, Zhang X, Zu M, Kang T, Liu S, Ke B, Xiao B. Multi-responsive nanococktails with programmable targeting capacity for imaging-guided mitochondrial phototherapy combined with chemotherapy. J Control Release 2020;327:371-83. [PMID: 32810527 DOI: 10.1016/j.jconrel.2020.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhang C, Chen Z, He Y, Xian J, Luo R, Zheng C, Zhang J. Oral colon-targeting core-shell microparticles loading curcumin for enhanced ulcerative colitis alleviating efficacy. Chin Med 2021;16:92. [PMID: 34551815 DOI: 10.1186/s13020-021-00449-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liang Y, He Q, Duan L, Gong H, Zu M, Xie D, Xiao B. Fluorinated hyaluronates endow oral nanoparticles with mucus penetration and colonic macrophage targeting properties. Smart Materials in Medicine 2021;2:250-9. [DOI: 10.1016/j.smaim.2021.07.003] [Reference Citation Analysis]
13 Li J, Hou W, Lin S, Wang L, Pan C, Wu F, Liu J. Polydopamine Nanoparticle-Mediated Dopaminergic Immunoregulation in Colitis. Adv Sci (Weinh) 2022;9:e2104006. [PMID: 34713621 DOI: 10.1002/advs.202104006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yang C, Merlin D. Can naturally occurring nanoparticle-based targeted drug delivery effectively treat inflammatory bowel disease? Expert Opin Drug Deliv 2020;17:1-4. [PMID: 31770040 DOI: 10.1080/17425247.2020.1698543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
15 Yang W, Xie D, Liang Y, Chen N, Xiao B, Duan L, Wang M. Multi-responsive fibroin-based nanoparticles enhance anti-inflammatory activity of kaempferol. Journal of Drug Delivery Science and Technology 2022;68:103025. [DOI: 10.1016/j.jddst.2021.103025] [Reference Citation Analysis]
16 Tang Y, Wang X, Li J, Nie Y, Liao G, Yu Y, Li C. Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a "Don't-Eat-Us" Strategy. ACS Nano 2019;13:13015-26. [PMID: 31689086 DOI: 10.1021/acsnano.9b05679] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 27.0] [Reference Citation Analysis]
17 Long D, Xiao B, Merlin D. Genetically modified silk fibroin nanoparticles for drug delivery: preparation strategies and application prospects. Nanomedicine 2020;15:1739-42. [DOI: 10.2217/nnm-2020-0182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pandey V, Haider T, Jain P, Gupta PN, Soni V. Silk as a leading-edge biological macromolecule for improved drug delivery. Journal of Drug Delivery Science and Technology 2020;55:101294. [DOI: 10.1016/j.jddst.2019.101294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
19 Chen K, Lou Y, Zhu Y. Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2021;2021:5548764. [PMID: 34211567 DOI: 10.1155/2021/5548764] [Reference Citation Analysis]
20 Cheng S, Shen H, Zhao S, Zhang Y, Xu H, Wang L, Di B, Xu L, Hu C. Orally administered mesoporous silica capped with the cucurbit[8]uril complex to combat colitis and improve intestinal homeostasis by targeting the gut microbiota. Nanoscale 2020;12:15348-63. [PMID: 32648873 DOI: 10.1039/d0nr03037f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zu M, Song H, Zhang J, Chen Q, Deng S, Canup BS, Yuan Y, Xiao B. Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis. Colloids and Surfaces B: Biointerfaces 2020;187:110747. [DOI: 10.1016/j.colsurfb.2019.110747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Xu Y, Zhu BW, Li X, Li YF, Ye XM, Hu JN. Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh2 for effective treatment of ulcerative colitis. Biomaterials 2022;280:121077. [PMID: 34890974 DOI: 10.1016/j.biomaterials.2021.121077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Zhang J, Zhao Y, Hou T, Zeng H, Kalambhe D, Wang B, Shen X, Huang Y. Macrophage-based nanotherapeutic strategies in ulcerative colitis. Journal of Controlled Release 2020;320:363-80. [DOI: 10.1016/j.jconrel.2020.01.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
24 Xiao L, Ding Z, Zhang X, Wang X, Lu Q, Kaplan DL. Silk Nanocarrier Size Optimization for Enhanced Tumor Cell Penetration and Cytotoxicity In Vitro. ACS Biomater Sci Eng 2021. [PMID: 34878245 DOI: 10.1021/acsbiomaterials.1c01122] [Reference Citation Analysis]
25 Yang J, Jia Z, Zhang J, Pan X, Wei Y, Ma S, Yang N, Liu Z, Shen Q. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance. Adv Healthc Mater 2022;:e2102799. [PMID: 35395704 DOI: 10.1002/adhm.202102799] [Reference Citation Analysis]
26 Liu S, Cao Y, Ma L, Sun J, Ramos-Mucci L, Ma Y, Yang X, Zhu Z, Zhang J, Xiao B. Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis. J Control Release 2022:S0168-3659(22)00288-7. [PMID: 35580812 DOI: 10.1016/j.jconrel.2022.05.025] [Reference Citation Analysis]
27 Wang H, Huang J, Ding Y, Zhou J, Gao G, Han H, Zhou J, Ke L, Rao P, Chen T, Zhang L. Nanoparticles Isolated From Porcine Bone Soup Ameliorated Dextran Sulfate Sodium-Induced Colitis and Regulated Gut Microbiota in Mice. Front Nutr 2022;9:821404. [DOI: 10.3389/fnut.2022.821404] [Reference Citation Analysis]
28 D'acunzo F, Masci G. Playing construction with the monomer toy box for the synthesis of multi‐stimuli responsive copolymers by reversible deactivation radical polymerization protocols. Journal of Polymer Science 2021;59:3059-83. [DOI: 10.1002/pol.20210590] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lu A, Petit E, Wang Y, Su F, Li S. Synthesis and Self-Assembly of Hydroxypropyl Methyl Cellulose- block -Poly(ε-caprolactone) Copolymers as Nanocarriers of Lipophilic Drugs. ACS Appl Nano Mater 2020;3:4367-75. [DOI: 10.1021/acsanm.0c00498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Zu M, Ma Y, Cannup B, Xie D, Jung Y, Zhang J, Yang C, Gao F, Merlin D, Xiao B. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv Drug Deliv Rev 2021;176:113887. [PMID: 34314785 DOI: 10.1016/j.addr.2021.113887] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
31 Zhang C, Li J, Xiao M, Wang D, Qu Y, Zou L, Zheng C, Zhang J. Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.110] [Reference Citation Analysis]
32 Abu Dayyih A, Alawak M, Ayoub AM, Amin MU, Abu Dayyih W, Engelhardt K, Duse L, Preis E, Brüßler J, Bakowsky U. Thermosensitive liposomes encapsulating hypericin: Characterization and photodynamic efficiency. Int J Pharm 2021;609:121195. [PMID: 34673168 DOI: 10.1016/j.ijpharm.2021.121195] [Reference Citation Analysis]
33 Xian J, Zhong X, Gu H, Wang X, Li J, Li J, Wu Y, Zhang C, Zhang J. Colonic Delivery of Celastrol-Loaded Layer-by-Layer Liposomes with Pectin/Trimethylated Chitosan Coating to Enhance Its Anti-Ulcerative Colitis Effects. Pharmaceutics 2021;13:2005. [PMID: 34959287 DOI: 10.3390/pharmaceutics13122005] [Reference Citation Analysis]
34 Tang Q, Zhang W, Zhang C, Guan Y, Ding J, Yuan C, Tan C, Gao X, Tan S. Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis. International Journal of Pharmaceutics 2020;586:119617. [DOI: 10.1016/j.ijpharm.2020.119617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm 2021;600:120461. [PMID: 33711470 DOI: 10.1016/j.ijpharm.2021.120461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhang X, Huang Y, Song H, Canup BSB, Gou S, She Z, Dai F, Ke B, Xiao B. Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics. J Control Release 2020;328:454-69. [PMID: 32890553 DOI: 10.1016/j.jconrel.2020.08.066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
37 Sun T, Kwong CHT, Gao C, Wei J, Yue L, Zhang J, Ye RD, Wang R. Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine. Theranostics 2020;10:10106-19. [PMID: 32929337 DOI: 10.7150/thno.48448] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
38 Long D, Merlin D. Micro- and nanotechnological delivery platforms for treatment of dysbiosis-related inflammatory bowel disease. Nanomedicine (Lond) 2021;16:1741-5. [PMID: 34196224 DOI: 10.2217/nnm-2021-0167] [Reference Citation Analysis]
39 Luo R, Lin M, Fu C, Zhang J, Chen Q, Zhang C, Shi J, Pu X, Dong L, Xu H, Ye N, Sun J, Lin D, Deng B, McDowell A, Fu S, Gao F. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment. Carbohydr Polym 2021;263:117998. [PMID: 33858583 DOI: 10.1016/j.carbpol.2021.117998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Zeng Z, He X, Li C, Lin S, Chen H, Liu L, Feng X. Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease. Biomaterials 2021;271:120753. [PMID: 33725585 DOI: 10.1016/j.biomaterials.2021.120753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Lin M, Dong L, Chen Q, Xu H, Han X, Luo R, Pu X, Qi S, Nie W, Ma M, Wang Y, Gao F, Zhang J. Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis. Front Bioeng Biotechnol 2021;9:702173. [PMID: 34513811 DOI: 10.3389/fbioe.2021.702173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Huang Y, Canup BSB, Gou S, Chen N, Dai F, Xiao B, Li C. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues. J Mater Chem B 2021;9:1604-15. [PMID: 33471012 DOI: 10.1039/d0tb02092c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Zhang G, Ma L, Bai L, Li M, Guo T, Tian B, He Z, Fu Q. Inflammatory microenvironment-targeted nanotherapies. J Control Release 2021;334:114-26. [PMID: 33887284 DOI: 10.1016/j.jconrel.2021.04.018] [Reference Citation Analysis]
44 Ma Y, Duan L, Sun J, Gou S, Chen F, Liang Y, Dai F, Xiao B. Oral nanotherapeutics based on Antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121410] [Reference Citation Analysis]
45 Gou S, Chen N, Wu X, Zu M, Yi S, Ying B, Dai F, Ke B, Xiao B. Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy. Acta Pharm Sin B 2022;12:406-23. [PMID: 35127395 DOI: 10.1016/j.apsb.2021.07.001] [Reference Citation Analysis]
46 Huang Y, Xie D, Gou S, Canup BSB, Zhang G, Dai F, Li C, Xiao B. Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer. Nanoscale 2021;13:5765-79. [PMID: 33704300 DOI: 10.1039/d0nr08579k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Luo R, Lin M, Zhang C, Shi J, Zhang S, Chen Q, Hu Y, Zhang M, Zhang J, Gao F. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chemistry 2020;330:127241. [DOI: 10.1016/j.foodchem.2020.127241] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
48 Zhang X, Zhao X, Tie S, Wang H, Tan M. Ultrasonic Self-Emulsification Nanocarriers for Cellular Enhanced Astaxanthin Delivery. J Agric Food Chem 2021;69:2719-28. [DOI: 10.1021/acs.jafc.0c05983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Bilal M, Nunes LV, Duarte MTS, Ferreira LFR, Soriano RN, Iqbal HMN. Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease. Mar Drugs 2021;19:196. [PMID: 33808253 DOI: 10.3390/md19040196] [Reference Citation Analysis]
50 Gosecka M, Gosecki M. Chemoresponsive polymer systems for selective molecular recognition of organic molecules in biological systems. Acta Biomater 2020;116:32-66. [PMID: 32877717 DOI: 10.1016/j.actbio.2020.08.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Ma Y, Zhou L, Yang C, Wang L, Yi S, Tong X, Xiao B, Chen J. Comparison of Sericins from Different Sources as Natural Therapeutics against Ulcerative Colitis. ACS Biomater Sci Eng 2021;7:4626-36. [PMID: 34469125 DOI: 10.1021/acsbiomaterials.1c00256] [Reference Citation Analysis]
52 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Lu M, Wu M, Huang Y, Yao J, Shao Z, Chen X. Animal protein-plant protein composite nanospheres for dual-drug loading and synergistic cancer therapy. J Mater Chem B 2022. [PMID: 35416829 DOI: 10.1039/d2tb00368f] [Reference Citation Analysis]
54 Xu S, Yang Q, Wang R, Tian C, Ji Y, Tan H, Zhao P, Kaplan DL, Wang F, Xia Q. Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis. Acta Biomater 2022;144:81-95. [PMID: 35288310 DOI: 10.1016/j.actbio.2022.03.012] [Reference Citation Analysis]
55 Mukhtar M, Ali H, Ahmed N, Munir R, Talib S, Khan AS, Ambrus R. Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer. Expert Opin Drug Deliv 2020;17:1239-57. [PMID: 32543950 DOI: 10.1080/17425247.2020.1783237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
56 Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
57 Liu P, Li Y, Wang R, Ren F, Wang X. Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease. Biomedicines 2022;10:85. [DOI: 10.3390/biomedicines10010085] [Reference Citation Analysis]
58 Du Y, Rong L, Cong Y, Shen L, Zhang N, Wang B. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opin Ther Targets 2021;25:191-209. [PMID: 33682588 DOI: 10.1080/14728222.2021.1901079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Li R, Lu F, Sun X, He L, Duan H, Peng W, Wu C. Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer’s Disease. IJN 2022;Volume 17:185-201. [DOI: 10.2147/ijn.s339979] [Reference Citation Analysis]
60 Lin Y, Wu Y, Su J, Wang M, Wu X, Su Z, Yi X, Wei L, Cai J, Sun Z. Therapeutic role of d-pinitol on experimental colitis via activating Nrf2/ARE and PPAR-γ/NF-κB signaling pathways. Food Funct 2021;12:2554-68. [PMID: 33625409 DOI: 10.1039/d0fo03139a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Chen Q, Ma Y, Bai P, Li Q, Canup BSB, Long D, Ke B, Dai F, Xiao B, Li C. Tumor Microenvironment-Responsive Nanococktails for Synergistic Enhancement of Cancer Treatment via Cascade Reactions. ACS Appl Mater Interfaces 2021;13:4861-73. [PMID: 33471499 DOI: 10.1021/acsami.0c20268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
62 Wang Y, Wang X, Lv Y, Guo Y, He M, Lan M, Zhao Y, Gao F. A ROS-responsive fluorescent probe detecting experimental colitis by functional polymeric nanoparticles. Int J Pharm 2021;609:121125. [PMID: 34560209 DOI: 10.1016/j.ijpharm.2021.121125] [Reference Citation Analysis]
63 Li CW, Li LL, Chen S, Zhang JX, Lu WL. Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases. Front Bioeng Biotechnol 2020;8:200. [PMID: 32258013 DOI: 10.3389/fbioe.2020.00200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
64 He W, Gao Y, Guo Z, Yang Z, Wang X, Liu H, Sun H, Shi B. Effects of fermented wheat bran and yeast culture on growth performance, immunity, and intestinal microflora in growing-finishing pigs. J Anim Sci 2021;99:skab308. [PMID: 34687291 DOI: 10.1093/jas/skab308] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Gou S, Xie D, Ma Y, Huang Y, Dai F, Wang C, Xiao B. Injectable, Thixotropic, and Multiresponsive Silk Fibroin Hydrogel for Localized and Synergistic Tumor Therapy. ACS Biomater Sci Eng 2020;6:1052-63. [DOI: 10.1021/acsbiomaterials.9b01676] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
66 Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release 2020;327:641-66. [PMID: 32911014 DOI: 10.1016/j.jconrel.2020.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
67 Wang K, Ma Q, Zhou H, Zhao J, Cao M, Wang S. Review on Fabrication and Application of Regenerated Bombyx Mori Silk Fibroin Materials. Autex Research Journal 2022;0. [DOI: 10.2478/aut-2021-0059] [Reference Citation Analysis]
68 Hu W, Fang T, Chen X. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis. Front Genet 2022;13:914384. [DOI: 10.3389/fgene.2022.914384] [Reference Citation Analysis]
69 Liu P, Gao C, Chen H, Vong CT, Wu X, Tang X, Wang S, Wang Y. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies. Acta Pharm Sin B 2021;11:2798-818. [PMID: 34589398 DOI: 10.1016/j.apsb.2020.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
70 Guo Z, Bai Y, Zhang Z, Mei H, Li J, Pu Y, Zhao N, Gao W, Wu F, He B, Xie J. Thermosensitive polymer hydrogel as a physical shield on colonic mucosa for colitis treatment. J Mater Chem B 2021;9:3874-84. [PMID: 33928321 DOI: 10.1039/d1tb00499a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Xu C, Chen S, Chen C, Ming Y, Du J, Mu J, Luo F, Huang D, Wang N, Lin Z, Weng Z. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy. Int J Pharm 2022;623:121884. [PMID: 35661797 DOI: 10.1016/j.ijpharm.2022.121884] [Reference Citation Analysis]
72 Cui DJ, Chen C, Yuan WQ, Yang YH, Han L. Integrative analysis of ferroptosis-related genes in ulcerative colitis. J Int Med Res 2021;49:3000605211042975. [PMID: 34510961 DOI: 10.1177/03000605211042975] [Reference Citation Analysis]
73 Kang C, Jung E, Hyeon H, Seon S, Lee D. Acid-activatable polymeric curcumin nanoparticles as therapeutic agents for osteoarthritis. Nanomedicine 2020;23:102104. [PMID: 31672600 DOI: 10.1016/j.nano.2019.102104] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
74 Ghalei S, Mondal A, Hopkins S, Singha P, Devine R, Handa H. Silk Nanoparticles: A Natural Polymeric Platform for Nitric Oxide Delivery in Biomedical Applications. ACS Appl Mater Interfaces 2020;12:53615-23. [DOI: 10.1021/acsami.0c13813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
75 Tie S, Tan M. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols. J Agric Food Chem . [DOI: 10.1021/acs.jafc.1c05012] [Reference Citation Analysis]
76 Zu M, Xie D, Canup BSB, Chen N, Wang Y, Sun R, Zhang Z, Fu Y, Dai F, Xiao B. 'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases. Biomaterials 2021;279:121178. [PMID: 34656857 DOI: 10.1016/j.biomaterials.2021.121178] [Reference Citation Analysis]
77 Zhang Z, Li A, Min X, Zhang Q, Yang J, Chen G, Zou M, Sun W, Cheng G. An ROS-sensitive tegafur-PpIX-heterodimer-loaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer. Biomater Sci 2021;9:221-37. [DOI: 10.1039/d0bm01519a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Qian C, Xin T, Xiao W, Zhu H, Zhang Q, Liu L, Cheng R, Wang Z, Cui W, Ge Z. Vascularized silk electrospun fiber for promoting oral mucosa regeneration. NPG Asia Mater 2020;12. [DOI: 10.1038/s41427-020-0221-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Moe YM, Nuntanaranont T, Khangkhamano M, Meesane J. Layer-by-layer particle deposited membranes of silk fibroin and poly (vinyl alcohol) for guided bone regeneration: molecular structure, morphology, and properties. Materials Technology. [DOI: 10.1080/10667857.2020.1842149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Xu H, Luo R, Dong L, Pu X, Chen Q, Ye N, Qi S, Han X, Nie W, Fu C, Hu Y, Zhang J, Gao F. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis. Nanomedicine 2022;39:102461. [PMID: 34562656 DOI: 10.1016/j.nano.2021.102461] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
81 Pham DT, Tiyaboonchai W. Fibroin nanoparticles: a promising drug delivery system. Drug Deliv 2020;27:431-48. [PMID: 32157919 DOI: 10.1080/10717544.2020.1736208] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
82 Ren Q, Sun S, Zhang X. Redox-active nanoparticles for inflammatory bowel disease. Nano Res 2021;14:2535-57. [DOI: 10.1007/s12274-021-3303-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Ahamad N, Kar A, Mehta S, Dewani M, Ravichandran V, Bhardwaj P, Sharma S, Banerjee R. Immunomodulatory nanosystems for treating inflammatory diseases. Biomaterials 2021;274:120875. [PMID: 34010755 DOI: 10.1016/j.biomaterials.2021.120875] [Reference Citation Analysis]
84 Ma Y, Tong X, Huang Y, Zhou X, Yang C, Chen J, Dai F, Xiao B. Oral Administration of Hydrogel-Embedding Silk Sericin Alleviates Ulcerative Colitis through Wound Healing, Anti-Inflammation, and Anti-Oxidation. ACS Biomater Sci Eng 2019;5:6231-42. [DOI: 10.1021/acsbiomaterials.9b00862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Zhang S, Kang L, Hu S, Hu J, Fu Y, Hu Y, Yang X. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease. Int J Biol Macromol 2021;167:1598-612. [PMID: 33220374 DOI: 10.1016/j.ijbiomac.2020.11.117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
86 Zaheer Y, Vorup‐jensen T, Webster TJ, Ahmed M, Khan WS, Ihsan A. Protein based nanomedicine: Promising therapeutic modalities against inflammatory disorders. Nano Select 2022;3:733-50. [DOI: 10.1002/nano.202100214] [Reference Citation Analysis]
87 Barani M, Rahdar A, Sargazi S, Amiri MS, Sharma PK, Bhalla N. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and Bio-Sensing Research 2021;32:100417. [DOI: 10.1016/j.sbsr.2021.100417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]